Click here to Login |
Contact us |
User Guide |
English
|
Français
This dataset preview is momentarily unavailable.
Please try again or select another dataset.
Pharmaceutical Market
Customise
Selection…
Variable [65 / 65]
Measure [9 / 9]
Country [48 / 48]
Year [12]
Layout
Table options
Export
Excel
Text file (CSV)
PC-axis
SDMX (XML)
Related files
My Queries
Save
Combine
Manage
Variable
Total pharmaceutical consumption
A-Alimentary tract and metabolism
A02A-Antacids
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)
A10-Drugs used in diabetes
B-Blood and blood forming organs
C-Cardiovascular system
C01A-Cardiac glycosides
C01B-Antiarrhythmics, Class I and III
C02-Antihypertensives
C03-Diuretics
C07-Beta blocking agents
C08-Calcium channel blockers
C09-Agents acting on the Renin-Angiotensin system
C10-Lipid modifying agents
G-Genito urinary system and sex hormones
G03-Sex hormones and modulators of the genital system
H-Systemic hormonal preparations, excluding sex hormones and insulins
J-Antiinfectives for systemic use
J01-Antibacterials for systemic use
M-Musculo-skeletal system
M01A-Antiinflammatory and antirheumatic products non-steroids
N-Nervous system
N02-Analgesics
N05B-Anxiolytics
N05C-Hypnotics and sedatives
N06A-Antidepressants
R-Respiratory system
R03-Drugs for obstructive airway diseases
Total pharmaceutical sales
Total pharmaceutical sales
A-Alimentary tract and metabolism
A02A-Antacids
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)
A10-Drugs used in diabetes
B-Blood and blood forming organs
C-Cardiovascular system
C01A-Cardiac glycosides
C01B-Antiarrhythmics, Class I and III
C02-Antihypertensives
C03-Diuretics
C07-Beta blocking agents
C08-Calcium channel blockers
C09-Agents acting on the Renin-Angiotensin system
C10-Lipid modifying agents
G-Genito urinary system and sex hormones
G03-Sex hormones and modulators of the genital system
H-Systemic hormonal preparations, excluding sex hormones and insulins
J-Antiinfectives for systemic use
J01-Antibacterials for systemic use
M-Musculo-skeletal system
M01A-Antiinflammatory and antirheumatic products non-steroids
N-Nervous system
N02-Analgesics
N05B-Anxiolytics
N05C-Hypnotics and sedatives
N06A-Antidepressants
R-Respiratory system
R03-Drugs for obstructive airway diseases
Products not elsewhere classified
Generic market
Total pharmaceutical market
Third-party-payer market
Community pharmacy market
Hospital pharmaceutical market
Year
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Measure
Country
Defined daily dosage per 1 000 inhabitants per day
Australia
(
D
)
80.4
(
D
)
88.9
(
D
)
91.7
(
B
D
)
96.2
(
D
)
100.7
(
D
)
104.1
(
D
)
106.5
(
D
)
109.3
(
D
)
112.2
(
D
)
115.6
122.2
..
Austria
(
D
)
54.2
(
D
)
57
(
D
)
58
(
D
)
59.3
(
D
)
60.3
(
D
)
60.3
(
D
)
60.5
(
D
)
61
(
D
)
61.3
(
D
)
62
(
D
)
63.2
..
Belgium
(
D
)
68.7
(
D
)
70
(
D
)
70.4
(
D
)
72.1
(
D
)
74.9
(
D
)
77.5
(
D
)
79
(
D
)
78.8
(
D
)
79.7
(
D
)
81.9
(
D
)
83.8
..
Canada
(
D
)
78.8
(
D
)
82.7
(
D
)
83.7
(
D
)
85
(
D
)
87.4
(
D
)
90.1
(
B
D
)
100.1
(
D
)
104.4
(
D
)
108.4
(
D
)
114.1
(
D
)
122
(
D
P
)
130.4
Chile
..
25.2
42.7
41.8
43.4
46.5
36.9
42
40.1
52
67
90.7
Costa Rica
21.9
24.4
26.1
29.7
29.9
28.4
29.3
30.9
33.4
35.9
39
..
Czech Republic
41.6
44.1
46.2
49
52.7
55
57.1
59.9
61.4
64.4
65.7
..
Denmark
84
85.2
83.2
80
76.6
77
76.4
75.7
76.6
78.3
80.7
84.6
Estonia
15.9
17.9
20.1
21.4
23.3
24.8
27.2
28.8
31.9
34.8
37
40.7
Finland
69.2
70.2
69.8
69.4
68.9
68.3
67.7
70.5
74.9
78.3
81.5
..
France
(
B
)
53.4
51.7
52
51.8
51.8
51.6
51.7
51.3
51.5
54.4
54.5
..
Germany
(
D
)
46.7
(
D
)
50
(
D
)
51.9
(
D
)
53.1
(
D
)
55.1
(
D
)
56.4
(
D
)
56.5
(
D
)
56.9
(
B
D
)
58.5
(
D
)
60.3
(
D
)
62.2
..
Greece
..
..
..
(
B
D
)
44.7
(
D
)
44.6
(
D
)
48.1
..
(
D
)
55.1
(
D
)
58
(
D
)
61
(
D
)
65.8
(
D
)
70.6
Hungary
(
D
)
26.4
(
D
)
27.3
(
D
)
26.8
(
D
)
27.5
(
D
)
27.7
(
D
)
28.3
(
D
)
28.4
(
D
)
28.8
(
D
)
29.3
(
D
)
29.5
(
D
)
30.4
(
D
)
29.8
Iceland
101.3
(
B
D
)
103.8
(
D
)
106.3
(
D
)
113.7
(
D
)
115.7
(
D
)
125.8
(
D
)
133
(
D
)
138.6
(
D
)
142
(
D
)
146
(
D
)
153.4
(
D
)
161.1
Israel
..
..
(
D
)
34.3
..
(
D
)
42.1
(
D
)
44.4
(
D
)
46.7
(
D
)
49.2
(
D
)
51.1
(
D
)
53.8
(
D
)
55.4
(
D
)
57.7
Italy
..
38.4
38.6
39.1
39.3
39.6
39.9
40.4
41.6
42.4
43.7
(
E
)
44.4
Korea
11.3
(
B
)
13.8
15.2
17
18
20.3
(
B
)
17.2
18.8
21
23.4
27.4
..
Latvia
..
..
9.5
10.2
11.1
12.3
13.3
15
16.1
17.6
19.8
21.5
Lithuania
19.2
20.8
23.4
24.7
25.7
27.9
29.3
32.1
31.3
35.4
36.8
..
Luxembourg
(
D
)
50.1
(
D
)
51.4
(
D
)
52
(
D
)
53.4
(
D
)
56
(
D
)
53.7
(
D
)
54.2
(
D
)
53
(
D
)
52.9
(
D
)
54.9
(
D
P
)
55.3
(
B
D
P
)
57.3
Netherlands
(
D
)
40.4
(
D
)
41.6
(
D
)
42.4
(
D
)
43.3
(
D
)
44.3
(
D
)
45.5
(
D
)
45.9
(
D
)
46.2
(
D
)
47.2
(
D
)
47.9
(
D
)
47.3
..
New Zealand
..
..
..
..
(
D
)
72.8
..
..
..
..
..
..
..
Norway
56.5
57.7
57.5
56.9
57.1
58
57.6
57.3
56.2
57.9
58.7
61.1
Portugal
(
D
)
78.7
(
D
)
78.3
(
D
)
84.5
(
D
)
87.5
(
D
)
92.1
(
D
)
95.1
(
D
)
99.5
(
D
)
103.8
(
D
)
109.3
(
D
)
123.7
(
D
)
131
(
D
)
139.6
Slovak Republic
29
30.7
30.2
35.2
38.1
40
(
B
)
38.9
39.4
41.1
47.6
48.2
..
Slovenia
(
D
)
44.1
(
D
)
50
(
D
)
51
(
D
)
53.3
(
D
)
55
(
D
)
56.8
(
D
)
58.6
(
D
)
59.5
(
D
)
61.5
(
D
)
63.3
(
D
)
63.6
..
Spain
(
D
)
61.2
(
D
)
63.9
(
D
)
64
(
D
)
65.2
(
B
D
)
71.3
(
D
)
73.1
(
D
)
75.5
(
D
)
77.2
(
B
)
80.4
83.6
86.9
(
P
)
92
Sweden
75.8
79.4
81.1
84.3
87.8
92.5
95
96.9
98.7
102.7
105.4
108.9
Türkiye
(
D
)
32.7
(
D
)
37
(
D
)
37.3
(
D
)
36.3
(
D
)
38.1
(
D
)
40.7
(
D
)
41
(
D
)
43.5
(
D
)
44.1
(
D
)
44.2
(
D
)
48.9
..
United Kingdom
(
D
)
65.9
(
D
)
70.7
(
D
)
75
(
B
D
)
82.3
(
D
)
87.8
(
D
)
94.2
(
D
)
100.1
(
D
)
107.9
..
..
..
..
Legend:
B
Break
D
Difference in methodology
E
Estimated value
P
Provisional value
Data extracted on 06 Jun 2023 02:00 UTC (GMT) from
OECD.Stat
Loading...
